-
Levodopa Initiation in Phase 3 Trials of Tavapadon, a Selective D1/D5 Agonist for Early Parkinson’s Disease
-
Levodopa Responsiveness and Motor Complication Trajectories in Parkinson’s Disease by α-Synuclein Seed Amplification Assay Status
-
Levodopa-Carbidopa Intestinal Gel Infusion Therapy in Advanced Parkinson’s Disease: Extension Study of Long-term outcomes of Single Centre experience
-
Levodopa-Induced Dyskinesia Predicts Falls, Fall-Related Injuries, and Their Consequences in Parkinson’s Disease: A Prospective PPMI Cohort Study
-
Levodopa-Induced Dyskinesias in Patients with Parkinson’s Disease in the Uzbek Population
-
Levodopa-induced peak-dyskinesia and motor fluctuations in corticobasal syndrome
-
Levodopa-Responsive Dystonia in Adenylosuccinate Lyase (ADSL) Deficiency Treated With Bilateral GPi Deep Brain Stimulation
-
Levodopa–Entacapone–Carbidopa Intestinal Gel (LECIG) Provides Sustained Improvement In Quality Of Life In Advanced Parkinson’s For Up To Two Years
-
Levodopa–Entacapone–Carbidopa Intestinal Gel in Advanced Parkinson’s Disease: a Four-Year Real-Life Experience
-
LFP-Based Deep Brain Stimulation Programming and Transition to Adaptive Deep Brain Stimulation in a Patient with Parkinson’s Disease: A Case Report from Thailand
- « Previous Page
- 1
- …
- 112
- 113
- 114
- 115
- 116
- …
- 208
- Next Page »
